Unknown PHASE2 INTERVENTIONAL 1-arm NCT01586715

Stem Cells Treatment for Extremely Complex Fistulae (HULPCIR)

A Phase IIa Clinical Trial to Study the Treatment of the Extremely Complex and Conventional Treatment Resistant Perianal Fistulae With Autologous Stem Cells From Lipoaspirate

Sponsor: Instituto de Investigación Hospital Universitario La Paz

Conditions Extremely Complex Perianal Fistulae

Interventions Adipose-derived stem cells without expanded

Updated 5 times since 2017 Last updated: Apr 25, 2012 Started: Mar 31, 2012 Primary completion: May 31, 2013 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Extremely Complex Perianal Fistulae and is currently ongoing. Instituto de Investigación Hospital Universitario La Paz leads this study, which shows 5 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Mar 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Instituto de Investigación Hospital Universitario La Paz

Data source: Instituto de Investigación Hospital Universitario La Paz

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madrid, Spain